Seung Chul Heo

Seung Chul Heo

Auto-generated profile, based on publicly available information

Seung Chul Heo

Department of Surgery, Seoul National University-Seoul Metropolitan Government (SNU-SMG) Boramae Medical Center, Seoul 07061, Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
JLJisoo Lee
Jisoo Lee
YKYoo-Sun Kim
Yoo-Sun Kim
JaeHwan LeeJaeHwan Lee
JaeHwan Lee
SHSeung Chul Heo
Seung Chul Heo
KLKook Lae Lee
Kook Lae Lee
Yuri KimYuri Kim
Yuri Kim
Walnut has been known for its health benefits, including anti-cardiovascular disease and anti-oxidative properties. However, there is limited evidence elucidating its effects on cancer stem cells (CSCs) which represent a small subset of cancer cells that provide resistance against chemotherapy. This study aimed to evaluate the anti-CSCs potential of walnut phenolic extract (WPE) and its bioactive compounds, including (+)-catechin, chlorogenic acid, ellagic acid, and gallic acid. In the present study, CD133+CD44+ cells were isolated from HCT116 cells using fluorescence-activated cell sorting (FACS) and then treated with WPE. As a result, survival of the CD133+CD44+ HCT116 cells was inhibited and cell differentiation was induced by WPE. In addition, WPE down-regulated the CSC markers, CD133, CD44, DLK1, and Notch1, as well as the β-catenin/p-GSK3β signaling pathway. WPE suppressed the self-renewal capacity of CSCs. Furthermore, the WPE exhibited stronger anti-CSC effects than its individual bioactive compounds. Finally, the WPE inhibited specific CSC markers in primary colon cancer cells isolated from primary colon tumor. These results suggest that WPE can suppress colon cancer by regulating the characteristics of colon CSCs.

1 January 2016 in Annals of Coloproctology
Verified
Journal Article
Open access
RSRumi Shin
Rumi Shin
SLSang Mok Lee
Sang Mok Lee
BSBeonghoon Sohn
Beonghoon Sohn
DLDong Woon Lee
Dong Woon Lee
ISInho Song
Inho Song
SHSeung Chul Heo
Seung Chul Heo
An intestinal perforation is a rare condition, but has a high mortality rate, even after immediate surgical intervention. The clinical predictors of postoperative morbidity and mortality are still not well established, so this study attempted to identify risk factors for postoperative morbidity and mortality after surgery for an intestinal perforation. We retrospectively analyzed the cases of 117 patients who underwent surgery for an intestinal perforation at a single institution in Korea from November 2008 to June 2014. Factors related with postoperative mortality at 1 month and other postoperative complications were investigated. The mean age of enrolled patients was 66.0 ± 15.8 years and 66% of the patients were male. Fifteen patients (13%) died within 1 month after surgical treatment. Univariate analysis indicated that patient-related factors associated with mortality were low systolic and diastolic blood pressure, low serum albumin, low serum protein, low total cholesterol, and high blood urea nitrogen; the surgery-related factor associated with mortality was feculent ascites. Multivariate analysis using a logistic regression indicated that low systolic blood pressure and feculent ascites independently increased the risk for mortality; postoperative complications were more likely in both females and those with low estimated glomerular filtration rates and elevated serum C-reactive protein levels. Various factors were associated with postoperative clinical outcomes of patients with an intestinal perforation. Morbidity and mortality following an intestinal perforation were greater in patients with unstable initial vital signs, poor nutritional status, and feculent ascites.

1 January 2022 in Nutrition Research and Practice
Verified
Journal Article
Open access
PDF file
KLKyung Eun Lee
Kyung Eun Lee
MKMinseo Kwon
Minseo Kwon
YKYoo Sun Kim
Yoo Sun Kim
YKYerin Kim
Yerin Kim
MCMin Gi Chung
Min Gi Chung
Yuri KimYuri Kim
Yuri Kim
Lee KE, et al. Nutr Res Pract. 2022 Apr;16(2):161-172. https://doi.org/10.4162/nrp.2022.16.2.161

1 March 2016 in Surgical Oncology
Verified
Journal Article
Closed access
ISIl Tae Son
Il Tae Son
SASoyeon Ahn
Soyeon Ahn
KPKyu Joo Park
Kyu Joo Park
JOJae Hwan Oh
Jae Hwan Oh
SJSeung-Yong Jeong
Seung-Yong Jeong
SKSung-Bum Kang
Sung-Bum Kang

17 January 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JLJoon-Hyop Lee
Joon-Hyop Lee
JAJiyoung Ahn
Jiyoung Ahn
WPWon Seo Park
Won Seo Park
ECEun Kyung Choe
Eun Kyung Choe
EKEunyoung Kim
Eunyoung Kim
HCHeejoon Chae
Heejoon Chae
Background: We investigated the associations between v-Raf murine sarcoma viral oncogene homolog B1 (BRAFV600E, henceforth BRAF) and v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations and colorectal cancer (CRC) prognosis, using The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GSE39582) datasets. Materials and Methods: The effects of BRAF and KRAS mutations on overall survival (OS) and disease-free survival (DFS) of CRC were evaluated. Results: The mutational status of BRAF and KRAS genes was not associated with overall survival (OS) or DFS of the CRC patients drawn from the TCGA database. The 3-year OS and DFS rates of the BRAF mutation (+) vs. mutation (−) groups were 92.6% vs. 90.4% and 79.7% vs. 68.4%, respectively. The 3-year OS and DFS rates of the KRAS mutation (+) vs. mutation (−) groups were 90.4% vs. 90.5% and 65.3% vs. 73.5%, respectively. In stage II patients, however, the 3-year OS rate was lower in the BRAF mutation (+) group than in the mutation (−) group (85.5% vs. 97.7%, p < 0.001). The mutational status of BRAF genes of 497 CRC patients drawn from the GSE39582 database was not associated with OS or DFS. The 3-year OS and DFS rates of BRAF mutation (+) vs. mutation (−) groups were 75.7% vs. 78.9% and 73.6% vs. 71.1%, respectively. However, KRAS mutational status had an effect on 3-year OS rate (71.9% mutation (+) vs. 83% mutation (−), p = 0.05) and DFS rate (66.3% mutation (+) vs. 74.6% mutation (−), p = 0.013). Conclusions: We found no consistent association between the mutational status of BRAF nor KRAS and the OS and DFS of CRC patients from the TCGA and GSE39582 databases. Studies with longer-term records and larger patient numbers may be necessary to expound the influence of BRAF and KRAS mutations on the outcomes of CRC.

1 December 2020 in Korean Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
SHSeung Chul Heo
Seung Chul Heo
HAHye Seong Ahn
Hye Seong Ahn
RSRumi Shin
Rumi Shin
CLChang-Sup Lim
Chang-Sup Lim
DHDong-Seok Han
Dong-Seok Han
Postoperative delirium (POD) is a common complication in elderly patients after major abdominal surgery for cancer. Although POD is related with a poor outcome, there have not been many reports about POD after abdominal surgery in Korea. The aims of study were to analyze the characteristics and surgical outcomes of elderly patients with POD and to identify the risk factors of POD. From November 2016 to January 2019, we prospectively enrolled 63 patients who were aged ≥75 years and underwent major abdominal surgery for cancer. POD was daily assessed for up to 10 days postoperatively with the Confusion Assessment Method and a validated chart review. POD occurred in eight patients (12.7%). Univariate analysis showed that the occurrence of POD was related to sodium <135 mEq/L (P=0.037), combined resection (P=0.023), longer surgery/anesthesia time (P=0.023 and P=0.037, respectively), increased blood loss (P=0.004), postoperative admission to intensive care unit (ICU) (P=0.023), and duration of Foley catheter (P=0.011), however, multivariate analysis identified no significant risk factors of POD. There was no difference in postoperative outcomes such as hospital stay, mortality, reoperation, and morbidity between patients with POD and without POD. Elderly patients with hyponatremia, combined resection, longer operation/anesthesia time and admission to ICU had tendencies to develop POD after major abdominal surgery. Surgeons should pay more attention to prevent POD, and a large-scale prospective study is needed to identify the risk factors of POD.